Primary contents from here.
Quarterly financial explanatory notes are available here.
FY Ending March 2026
FY Ending March 2025
- P20 "Capital Adequacy Ratio (non-consolidated: Okasan Securities)" of 1Q and 2Q have been revised (Revision date : November 19, 2024)
- P20 "Capital Adequacy Ratio (non-consolidated: Okasan Securities)" of 3Q and 4Q have been revised (Revision date : July 30, 2025)
FY Ending March 2024
- The figure for 21/3 on P21 "ROE" of 4Q Results Briefing has been revised (Revision date : October 30, 2024)